Serum Sclerostin in Hepatitis C Virus Infected Patients

BACKGROUND: Sclerostin inhibits osteoblast functions, differentiations, and survival rates. As an endogenous inhibitor of the Wnt/β-catenin pathway, the sclerostin should be related to decreased bone masses, although several studies indicate opposite results. In addition, it may be related to insuli...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: González-Reimers, Emilio, López-Prieto, Javier, Pelazas-González, Ricardo, Alemán-Valls, M.Remedios, José de la Vega-Prieto, María, Jorge-Ripper, Carlos, Durán-Castellón, M. Carmen, Santolaria-Fernández, F
Format: Artigo
Idioma:Inglês
Publicat: The Korean Society for Bone and Mineral Research 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3970296/
https://ncbi.nlm.nih.gov/pubmed/24707469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11005/jbm.2014.21.1.69
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars